Skip to main content

BHR Hip THA Cases To Have A Special Mediator

BHR Hip THA Cases To Have A Special Mediator

BHR Hip THA Cases To Have A Special Mediator

Introduction

Judge Catherine C. Blake of the U.S. District Court for the District of Maryland appointed John W. Perry Jr. of Perry Dampf Dispute Resolutions as a special mediator to oversee the parties involved in the settlement of Smith & Nephew Birmingham Hip Resurfacing MDL docket. The mediator is expected to assist the parties in settlement of approximately 100 Total Hip Arthroplasty (THA) and R3 Acetabular System cases that are pending in the hip replacement MDL.

More than 400 product liability lawsuits are pending against the manufacturer of BHR systems over allegations of failure to warn about the design defects of the metal-on-metal hip implant, which is prone to wear and tear, loosening, dislocation, and metallosis often requiring removal of the device. The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated the hip implants lawsuits in the District of Maryland as a part of a federal MDL for coordinated pretrial proceedings.

In a similar hip implant litigation, lawsuits continue to be filed involving complications over Stryker Hip Replacement system centralized before U.S. District Judge Indira Talwani under MDL No. 2768 – in Re: Stryker LFIT V40 Femoral Head Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.